Reproductive Medicine Associates of New Jersey

Open enrollment with a later-stage pipeline tilt

According to ClinicalTrials.gov-derived indexes, Reproductive Medicine Associates of New Jersey sits in the top decile of US sponsors by registered trial count (#372 of 15,742 sponsors by registered trial count).

51 total trials 7 currently recruiting 38 completed later-stage tilt top decile by trial count

Reproductive Medicine Associates of New Jersey: 51 sponsored US clinical trials, 7 recruiting.

Reproductive Medicine Associates of New Jersey sponsors 51 registered US clinical trials on ClinicalTrials.gov, 7 of them currently recruiting, and 38 completed. 1 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Infertility, with 6 trials.

Top-decile sponsor footprint

Reproductive Medicine Associates of New Jersey ranks in the top decile of sponsors by registered trial count (#372 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 55/100

38 of 44 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

51 total, page 1 of 2

RECRUITING NA

Investigating Micro-Manipulation Procedures for Assisted Hatching Timing

NCT06377917
RECRUITING NA

The EPIC Study: Exploring Paternal Age and the Influence on Blastocyst Culture

NCT06629766
RECRUITING

Male Infertility and Assisted Reproductive Technologies Research Biobank

NCT06880302
RECRUITING

Quantifying Uterine Elastography in Menstruating Women

NCT06816381
RECRUITING NA

Validating Incubators in the Lab: Optimizing Culture and Investigating blasTulation Yield

NCT06214936
RECRUITING NA

Platelet Rich Plasma for Insufficient Endometrium

NCT05538338
RECRUITING

Discarded Materials Study

NCT01219335
TERMINATED NA

PRogrammed Versus Modified Natural Cycle After Euploid Failed Embryo Transfer

NCT06074055
COMPLETED

FirmTech User Research Trial

NCT05853822
COMPLETED

Uterine Elastography: a Potential Predictor of Embryo Transfer Success

NCT05397912
TERMINATED NA

Prospective Assessment of Impact of Personalized Dosing of Low-dose Human Chorionic Gonadotropin (hCG) on in Vitro Fertilization (IVF) Outcomes

NCT04852029
COMPLETED NA

The Effect of Embryo Culture Under a Continuous CO2 Setting Versus a Sequential CO2 Setting

NCT04693806
COMPLETED NA

Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen

NCT04496284
COMPLETED NA

Oocyte Survival After Vitrification With Slush Nitrogen Compared With Liquid Nitrogen

NCT04342364
COMPLETED NA

Ovarian Rejuvenation for Premature Ovarian Insufficiency and Poor Ovarian Response

NCT04163640
COMPLETED

Transcriptomic Evaluation of Endometrial Receptivity

NCT04141085
TERMINATED NA

Endometrial Rejuvenation Study

NCT04045821
TERMINATED NA

Fresh Vs Frozen Surgical Sperm in IVF

NCT03361982
TERMINATED

Round Spermatid Injection Protocol

NCT04053309
COMPLETED

Pathways to Fatherhood

NCT03966352
COMPLETED

Embryo DNA Repair Capacity Project

NCT03953859
COMPLETED

The Human Microbiome and IVF Outcomes

NCT03637777
COMPLETED

Predictive Value of Embryonic Testing

NCT03604107
TERMINATED

Split Cohort Trial Comparing IVF Outcomes After the Use of Testicular vs. Ejaculated Sperm for ICSI

NCT03483298
COMPLETED

Embryonic Ploidy Status in the Oncofertility Population

NCT03350230
COMPLETED

Pregnancy Outcomes After Uterine Cavity Expansion

NCT03218878
COMPLETED NA

Evaluation of the Impact of Reduced Oxygen Concentration on Live Birth Rate

NCT03147872
COMPLETED NA

Evaluation of the Impact of Reduced Oxygen Concentration on Embryonic Development

NCT02919384
COMPLETED

Endometrial Receptivity Profile in Patients With Endometrial Proliferation Defects

NCT02406690
COMPLETED NA

EnMotion, Embryo's Natural Motion

NCT02467725
COMPLETED

Effects of Varied Estrogen Doses on Endometrial Receptivity

NCT02458404
COMPLETED

Correlating In Vitro Fertilization Outcomes After Euploid Blastocyst Transfer With Sperm DNA Fragmentation

NCT02268123
COMPLETED

Predicting Normal vs. Carrier Status in Euploid Embryos of Translocation Carriers

NCT02178865
COMPLETED NA

Next Generation Sequencing Screening for Embryonic Ploidy Status

NCT02032264
COMPLETED NA

Screening of Low Responders for Aneuploidy to Improve Reproductive Efficiency

NCT01977144
COMPLETED Phase 4

Sequential vs. Monophasic Media Impact Trial (SuMMIT)

NCT01917240
COMPLETED

Natural Cycle In Vitro Fertilization

NCT01866618
COMPLETED NA

Intrauterine Human Chorionic Gonadotropin at the Time of Embryo Transfer

NCT01643993
COMPLETED NA

Optimizing the Temperature for Embryo Culture in In Vitro Fertilization

NCT01506089
COMPLETED NA

Single Embryo Transfer of a Euploid Embryo Versus Double Embryo Transfer

NCT01408433
COMPLETED NA

Evaluation of the Impact of Vitrification on Oocytes

NCT01223118
COMPLETED

Study of the Efficacy of 24 Chromosome Preimplantation Genetic Diagnosis (PGD)

NCT01219283
COMPLETED

Evaluation of the Impact of Embryo Biopsy on the Reproductive Potential of Embryos Undergoing In Vitro Fertilization (IVF)

NCT01219504
COMPLETED NA

Validation of the Accuracy of DNA Fingerprinting Using Polar Bodies and Embryonic Cells

NCT01219517
COMPLETED

Egg Donor Recipient Characteristics Preferences

NCT01219491
COMPLETED

Evaluation of Discarded Laboratory Pathological Specimens and Media

NCT01219439
COMPLETED

Study of Ovum Donors After Donation

NCT01219374
COMPLETED

Evaluation of Anti-mullerian Hormone Levels as Predictive of IVF Outcomes in Women Over 38 Years Old

NCT01219387
COMPLETED NA

Use of r-hLH (Luveris) in Donors Previously Treated With r-hFSH (Gonal F)

NCT01223079
COMPLETED NA

Laser Acupuncture Before and After Embryo Transfer Improves IVF Outcomes

NCT02815371
Page 1 of 2 Next →

Phase Distribution

PhaseTrial count
Phase 4 1

Therapeutic Areas

Infertility 6
Infertility (IVF Patients) 3
Luteal Phase Defect 1
Conditioned IVF Media 1
Follicular Fluid 1
Granulosa Cells 1
Seminal Fluid 1
Extra Spermatozoa 1
Non-viable Oocytes 1
All Patients Undergoing Infertility Treatment 1

Where Reproductive Medicine Associates of New Jersey enrollment is open (later-stage tilt)

7 recruiting of 51 indexed (14% open); 38 completed (75%).

Phase mix: 1 late (III/IV) vs 0 early (I/II) (later-stage heavy).

Top condition: Infertility (6 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Reproductive Medicine Associates of New Jersey: open-pipeline peers nationwide

Peers matched on 51 registered trials and 14% open enrollment, not the therapeutic-area sidebar.

Reproductive Medicine Associates of New Jersey sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0200400600 0%5%10%15% Total trials Recruiting share Reproductive Medicine Associates of New JerseyColgate PalmoliveMedtronicNeuroOhio UniversityTexas Woman's UniversityLindenwood UniversityVirginia Commonwealth UniversityFate TherapeuticsInMode MD
Reproductive Medicine Associates of New Jersey sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Reproductive Medicine Associates of New Jersey sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 51 trials (± recruiting share)

Sponsors near 14% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Reproductive Medicine Associates of New Jersey page

51 registered trials is a research-attention snapshot, not an endorsement of Reproductive Medicine Associates of New Jersey or any single study.

  • 7 of Reproductive Medicine Associates of New Jersey's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Infertility is the condition Reproductive Medicine Associates of New Jersey studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Infertility trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Reproductive Medicine Associates of New Jersey pipeline card: 51 registered trials from official public datasets.Report a data error.